GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Zhejiang Ausun Pharmaceutical Co Ltd (SHSE:603229) » Definitions » Shiller PE Ratio

Zhejiang Ausun Pharmaceutical Co (SHSE:603229) Shiller PE Ratio : 42.56 (As of Apr. 13, 2025)


View and export this data going back to 2017. Start your Free Trial

What is Zhejiang Ausun Pharmaceutical Co Shiller PE Ratio?

As of today (2025-04-13), Zhejiang Ausun Pharmaceutical Co's current share price is ¥7.66. Zhejiang Ausun Pharmaceutical Co's E10 for the quarter that ended in Sep. 2024 was ¥0.18. Zhejiang Ausun Pharmaceutical Co's Shiller PE Ratio for today is 42.56.

The historical rank and industry rank for Zhejiang Ausun Pharmaceutical Co's Shiller PE Ratio or its related term are showing as below:

SHSE:603229' s Shiller PE Ratio Range Over the Past 10 Years
Min: 26.38   Med: 29.52   Max: 42.98
Current: 42.56

During the past years, Zhejiang Ausun Pharmaceutical Co's highest Shiller PE Ratio was 42.98. The lowest was 26.38. And the median was 29.52.

SHSE:603229's Shiller PE Ratio is ranked worse than
62.59% of 147 companies
in the Biotechnology industry
Industry Median: 32.4 vs SHSE:603229: 42.56

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Zhejiang Ausun Pharmaceutical Co's adjusted earnings per share data for the three months ended in Sep. 2024 was ¥0.060. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is ¥0.18 for the trailing ten years ended in Sep. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Zhejiang Ausun Pharmaceutical Co Shiller PE Ratio Historical Data

The historical data trend for Zhejiang Ausun Pharmaceutical Co's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhejiang Ausun Pharmaceutical Co Shiller PE Ratio Chart

Zhejiang Ausun Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Zhejiang Ausun Pharmaceutical Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - 46.86

Competitive Comparison of Zhejiang Ausun Pharmaceutical Co's Shiller PE Ratio

For the Biotechnology subindustry, Zhejiang Ausun Pharmaceutical Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zhejiang Ausun Pharmaceutical Co's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Zhejiang Ausun Pharmaceutical Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Zhejiang Ausun Pharmaceutical Co's Shiller PE Ratio falls into.


;
;

Zhejiang Ausun Pharmaceutical Co Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Zhejiang Ausun Pharmaceutical Co's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=7.66/0.18
=42.56

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zhejiang Ausun Pharmaceutical Co's E10 for the quarter that ended in Sep. 2024 is calculated as:

For example, Zhejiang Ausun Pharmaceutical Co's adjusted earnings per share data for the three months ended in Sep. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Sep. 2024 (Change)*Current CPI (Sep. 2024)
=0.06/115.7848*115.7848
=0.060

Current CPI (Sep. 2024) = 115.7848.

Zhejiang Ausun Pharmaceutical Co Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201212 0.000 95.237 0.000
201312 0.000 97.624 0.000
201412 0.000 99.000 0.000
201503 0.046 99.900 0.053
201512 0.000 100.600 0.000
201603 0.022 102.200 0.025
201606 0.015 101.400 0.017
201609 0.024 102.400 0.027
201612 0.043 102.600 0.049
201703 0.022 103.200 0.025
201706 0.020 103.100 0.022
201709 0.009 104.100 0.010
201712 0.030 104.500 0.033
201803 0.002 105.300 0.002
201806 0.029 104.900 0.032
201809 0.011 106.600 0.012
201812 0.015 106.500 0.016
201903 0.011 107.700 0.012
201906 0.032 107.700 0.034
201909 0.027 109.800 0.028
201912 0.009 111.200 0.009
202003 0.027 112.300 0.028
202006 0.033 110.400 0.035
202009 0.018 111.700 0.019
202012 0.029 111.500 0.030
202103 0.055 112.662 0.057
202106 0.052 111.769 0.054
202109 0.031 112.215 0.032
202112 0.046 113.108 0.047
202203 0.092 114.335 0.093
202206 0.066 114.558 0.067
202209 0.069 115.339 0.069
202212 0.071 115.116 0.071
202303 0.114 115.116 0.115
202306 0.080 114.558 0.081
202309 0.078 115.339 0.078
202312 0.037 114.781 0.037
202403 0.136 115.227 0.137
202406 0.084 114.781 0.085
202409 0.060 115.785 0.060

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Zhejiang Ausun Pharmaceutical Co  (SHSE:603229) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Zhejiang Ausun Pharmaceutical Co Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Zhejiang Ausun Pharmaceutical Co's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Zhejiang Ausun Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
No.5, Donghai 4th Avenue, chemical raw materials base Linhai Park East, Zhejiang Province, Taizhou, CHN, 317016
Zhejiang Ausun Pharmaceutical Co Ltd is mainly engaged in the research and development, production and sales of specialty APIs and pharmaceutical intermediates, as well as providing customized production and research for customers. Its products portfolio includes Prostaglandins and their intermediates, Raw material medicine, Fluorine series and Develop products.
Executives
Zheng Zhi Guo Directors, senior managers
Zhang Hua Dong Directors, senior managers
Liu Bing Director

Zhejiang Ausun Pharmaceutical Co Headlines

No Headlines